Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (45)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by REDWOOD, M.
Right arrow Articles by MATTHEWS, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by REDWOOD, M.
Right arrow Articles by MATTHEWS, J. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

The Association of Age with Dosage Requirement for Warfarin

M. REDWOOD, CLARE TAYLOR, BARBARA J. BAIN and J. H. MATTHEWS

Department of Haematology, St Mary's Hospital and Medical School Norfolk Place, London W2 1PG

Address correspondence to Dr B. J. Bain

Two groups of patients have been studied in order to investigate the relationship between age and the effect of oral anticoagulant therapy. The first group comprised 364 patients aged 23–89 years who showed a stable anticoagulant effect on medium- or long-term warfarin therapy; in this group the elderly subjects were found to require, on average, a lower drug dose to maintain the same degree of anticoagulation. The second group comprised 130 patients aged 15–83 years who had received an initial standard oral dose of 10 mg of warfarin. No significant difference was found in the degree of anticoagulation achieved by 16 hours. Although the maintenance dose in elderly patients is somewhat lower than in younger, the same protocols can be used for the introduction of therapy.

Received October 2, 1990; Revision received October 2, 1990.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti
Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 160S - 198S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Garcia, S. Regan, M. Crowther, R. A. Hughes, and E. M. Hylek
Warfarin Maintenance Dosing Patterns in Clinical Practice: Implications for Safer Anticoagulation in the Elderly Population
Chest, June 1, 2005; 127(6): 2049 - 2056.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. L. Singla and G. B. Morrill
Warfarin maintenance dosages in the very elderly
Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1062 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek
The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 204S - 233S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Ansell, J. Hirsh, J. Dalen, H. Bussey, D. Anderson, L. Poller, A. Jacobson, D. Deykin, and D. Matchar
Managing Oral Anticoagulant Therapy
Chest, January 1, 2001; 119 (2009): 22S - 38S.
[Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
V. Pengo, A. Zasso, F. Barbero, A. Biasiolo, P. Rampazzo, and T. Brocco
Initiation of Warfarin Treatment in Outpatients with Nonrheumatic Atrial Fibrillation: A Scheme for Early Indication of Maintenance Dose
Clinical and Applied Thrombosis/Hemostasis, October 1, 1998; 4(4): 274 - 276.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.